Senna and Duragesic-50 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna (senna) and Duragesic-50 (fentanyl). Common drug interactions include decreased appetite among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Senna and Duragesic-50. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Duragesic-50?

Duragesic-50 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 733 Duragesic-50 users. Check the latest studies of Duragesic-50.



On Jul, 13, 2026

12 people who take Senna and Duragesic-50 together, and have interactions are studied.

Senna and Duragesic-50 drug interactions.

What are the common drug interactions of Senna and Duragesic-50, by gender? *:

female:

  1. Decreased appetite
  2. Dental caries
  3. Depression
  4. Dry mouth
  5. Headache (pain in head)
  6. Nausea (feeling of having an urge to vomit)
  7. Neuropathy peripheral (surface nerve damage)
  8. Oedema peripheral (superficial swelling)
  9. Onychomycosis (fungal infection of the nail)
  10. Osteomyelitis (infection of bone)

male:

  1. Anxiety
  2. Injury
  3. Deformity (disfigurement)
  4. Depression
  5. Discomfort
  6. Emotional distress
  7. Failure to thrive (inadequate weight gain and physical growth in children)
  8. Haematochezia (passage of stools containing blood)
  9. Hypophagia (reduced food intake)
  10. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)

What are the common drug interactions of Senna and Duragesic-50, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Light chain analysis increased
  2. Mucosal inflammation (infection of mucous membrane)
  3. Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord)
  4. Neoplasm malignant (cancer tumour)
  5. Neuralgia (pain in one or more nerves)
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteoporosis (bones weak and more likely to break)
  9. Pleural fibrosis (formation of fibrous tissue in lung)
  10. Post laminectomy syndrome

60+:

  1. Anxiety
  2. Asthenia (weakness)
  3. Cellulitis (infection under the skin)
  4. Cerebral disorder (brain disease)
  5. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  6. Chromatopsia (visual defect in which colourless objects appear to be tinged with colour)
  7. Colonic polyp (extra part of colon tissue grow in intestine)
  8. Confusional state
  9. Conjunctivitis (pink eye)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 33.33%
  2. Skin Ulcer: 2 people, 16.67%
  3. Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 16.67%
  5. Diabetes: 2 people, 16.67%
  6. Thyroid Diseases: 1 person, 8.33%
  7. Prostate Cancer: 1 person, 8.33%
  8. Neck Pain: 1 person, 8.33%
  9. Muscle Spasms (muscle contraction): 1 person, 8.33%
  10. High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Duragesic-50?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Senna and Duragesic-50:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Duragesic-50:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Senna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duragesic-50 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on senna and fentanyl (the active ingredients of Senna and Duragesic-50, respectively), and Senna and Duragesic-50 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: